In addition, In vivo tumor formation assays showed that elevated levels of DNAAF5 promote HCC cell proliferation rates, and after USP39 knockdown in Hep3B-ov-DNAAF5 cells, the increased tumor volume due to increased expressions of DNAAF5 was significantly decreased (Figure 6C). This evidence concerns the gene USP39 and hepatocellular carcinoma.